arrow
N

Nicholas Thomas

uk health security agency (ukhsa)
H指数:18
被引数:2,121

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
2024-10-010
OAAI
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes ( vol 47, pg 1276, 2024)

监测胰岛自身抗体阳性前期3型糖尿病患者的共识指南 (第47卷,1276页,2024)

2024-09-060
PRE
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes (JUN, 10.1007/s00125-024-06205-5, 2024)

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南 (JUN,10.1007/s00125-024-06205-5,2024)

2024-09-040
OAAI
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南

2024-06-243
OAAI
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南

2024-06-248
OA
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024
2024-04-034
OAAI
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

molnupiravir在高危成人门诊患者中SARS-CoV-2病毒和抗体反应的随机对照试验

2024-02-2310
OAAI
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial

莫那比拉韦对高危社区新型冠状病毒肺炎成人的成本效用分析: 全景试验的经济评估

2024-01-162
OAAI
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
LANCET
IF88.5
2023-01-01237
OAAI
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
2022-03-2328
OAAI
Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary care
2021-12-2127
OA
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
2021-09-0155
OAAI
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
LANCET
IF88.5
2021-09-01157
OAAI
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
LANCET
IF88.5
2021-03-01190
OAAI
The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms
2020-07-0239
OAAI
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England
2020-04-0253
OAAI